Topic
Clinical Trials
55 Podcasts • 16 Cases • 8 Courses on BackTable
Episode # 336 • 15 Oct 2026
Biomarkers in Treatment Intensification for Prostate Cancer
Same risk group, very different benefit. Can biomarkers help identify who needs treatment intensification in prostate cancer? On this episode of BackTable Urology, Dr. Ruchika Talwar and Dr. Angela Jia, a radiation oncologist at University Hospitals Cleveland Medical Center, break down the difference between prognostic and predictive biomarkers and how genomic testing is informing the way clinicians counsel patients. They review trial data suggesting that men with a low genomic score may gain little from adding hormone therapy, along with early prospective evidence that the luminal B subtype may help identify who benefits most from intensification.
This podcast is supported by
More on Clinical Trials
Loading recent podcasts…
Urology # 336
Oct 14, 2026
with Dr. Angela Jia, Dr. Ruchika Talwar
Same risk group, very different benefit. Can biomarkers help identify who needs treatment intensification in prostate...
Vascular & IR # 671
Aug 24, 2026
with Dr. Timothy Fernandes, Dr. Robert Lookstein, Dr. Harris Chengazi
Once your PERT is assembled, how do you navigate the evolving pulmonary embolism (PE) literature to improve patient...
2,700+ listens
Tumor Board # 74
Jul 27, 2026
with Dr. Chih-Yi Liao, Dr. Robert Ramirez, Dr. Lingling Du
What first-line therapies should be considered for patients with higher-grade, metastatic neuroendocrine tumors (NETs)?...
Urology # 314
Jul 6, 2026
with Dr. Rana McKay, Dr. Emmanuel Antonarakis, Dr. Alan Tan
With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for...
1,000+ listens
Cardiology # 50
Aug 31, 2026
with Dr. Timothy Fernandes, Dr. Robert Lookstein, Dr. Harris Chengazi
Once your PERT is assembled, how do you navigate the evolving pulmonary embolism (PE) literature to improve patient...
Tumor Board # 75
Aug 3, 2026
with Dr. Cathy Eng, Dr. Jun Gong
Is it time to rethink the definition of “cure” for stage IV colorectal cancer? In this episode of BackTable Tumor...
1,800+ listens
Tumor Board # 71
Jul 6, 2026
with Dr. Rana McKay, Dr. Emmanuel Antonarakis, Dr. Alan Tan
With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for...
Tumor Board # 68
Jun 22, 2026
with Dr. Dawood Findakly, Dr. Gregory Botta
Can the latest therapies, lessons from clinical trials, and a focus on emotional support improve outcomes for patients...
Tumor Board Case
Jun 23, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Tumor Board Case
Jun 23, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Tumor Board Case
Jun 16, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
Tumor Board Case
Jun 16, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
Tumor Board Case
Jun 23, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Tumor Board Case
Jun 23, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Tumor Board Case
Jun 16, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
Tumor Board Case
Jun 16, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
Urology Course
3 hours, 28 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.